Matched, SAR444656 clinical trials

A multinational, multicenter, double-blind, placebo-controlled phase 2 study to evaluate efficacy and safety of SAR444656 in adult participants with moderate to severe atopic dermatitis.

This study is testing a new medicine, SAR444656, for adults with moderate to severe eczema (atopic dermatitis). We want to see if it helps improve the skin and reduce symptoms like itching, and if it's safe to use.